Nutriband (NASDAQ: NTRB) Investor Webinar FAQ
Summary
What is the purpose of the Nutriband investor webinar?
The webinar aims to provide investors with insights into Nutriband’s current operations and upcoming milestones, particularly focusing on its transdermal technology developments.
When and where is the Nutriband investor webinar taking place?
The webinar is scheduled for July 25, 2024, at 4:15 p.m. ET and will be hosted online by RedChip Companies.
Who will be speaking at the Nutriband investor webinar?
Nutriband Chairman and President Serguei Melnik and CEO Gareth Sheridan will be the key speakers at the webinar.
How can I register for the Nutriband investor webinar?
Interested participants can register for the free webinar by visiting the registration link provided: https://ibn.fm/ZZkgn.
What is Nutriband Inc.’s main focus?
Nutriband is primarily engaged in the development of transdermal pharmaceutical products, with a lead product being an abuse-deterrent fentanyl patch incorporating its AVERSA™ technology.
What is AVERSA technology?
AVERSA technology is Nutriband’s proprietary abuse-deterrent technology that can be incorporated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Where can I find more information about Nutriband Inc.?
More information about Nutriband can be found on their official website: www.Nutriband.com or in their newsroom at https://ibn.fm/NTRB.
What are the benefits of attending the Nutriband investor webinar?
Attendees will gain direct insights from Nutriband’s leadership about the company’s progress, future directions, and how its technologies address significant challenges in pharmaceutical abuse and misuse.
Is there a cost to attend the Nutriband investor webinar?
No, the webinar is free to attend. Registration is required via the provided link: https://ibn.fm/ZZkgn.
Who is hosting the Nutriband investor webinar?
The webinar is hosted by RedChip Companies, a part of the InvestorBrandNetwork, which specializes in investor communications and outreach.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 131658